Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 100 Million+ Visitors
  • 75000+ Unique visitors per conference
  • 100000+ Page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Recommended Global Oncology & Cancer Webinars & Conferences

Europe & UK
Asia Pacific & Middle East
Canada

Cancer and Care 2022

About Conference


Organizing committee of Cancer and Care 2022 invites all the participants from all over the world to attend “Annual Conference on Cancer Research”going to be held in April 18-19, 2022 Miami, USA.The primary topic of the conference is "Exploring Advancements in Cancer Care".

Cancer and Care 2022 is a global platform for keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects.The conference invites Pathologists, Oncologists, Radiologists, Academicians, Clinical Researchers, Students, Young researchers, Medical Devices Companies and business delegates across the globe to share views, exchange knowledge and establish research collaborations & networking.

Why to attend:

Cancer and Care 2022 is an international platform for presenting research about diagnosis, prevention and management and exchanging ideas about it and thus contributes to the dissemination of knowledge in Cancer Care and Research for the benefit of both the academics and business.

The organizing committee of this Cancer and Care 2022 Conference is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Cancer and  Care 2022, where you will be sure to have a meaningful experience with scholars from all around the world. All members of the Cancer and  Care  Conference and Organizing Committee look forward to meeting you in Miami, USA.

Scientific Sessions

 Session 1:Cancer prevention and Care 

Cancer prevention is an accomplishment drugs towards lower chance of getting cancer. In 2019, 1.8 million people were diagnosed with cancer in the United States. Not only the physical problems but also the emotional distress was caused by cancer, the expensive costs of care are also an obligation to patients, their families, and to the public. With the prevention cancer, the number of new cases of cancer can be reduced. Expectantly, this will moderate the load of cancer and cancer death number will decrease. Cancer can be Aspects handled by many treatments like chemotherapy, radiation therapy, hormonal therapy, target therapy, and palliative care.

  • Psychological
  • Hereditary Aspects
  • Food Habitats
  • Immunized Aspects
  • Chronic Inflammation

Session 2:Cancer Vaccines

Cancer vaccines generally either treats existing cancer or prevents development of a cancer. Cancer treatment vaccines are made up of cancer cells, parts of cells, or pure antigens. Sometimes a patient’s own immune cells are removed and exposed to these substances in the lab to create the vaccines.

  • Cancer Vaccines
  • CAR T-Cell Therapy
  • Oncolytic viral therapies
  • Gene therapy
  • Adoptive T-Cell transfer
  • Oncoviruses
  • Therapeutic Cancer Vaccines
  • HPV & Hepatitis B vaccine
  • Personalised Cancer Vaccines
  • Clinical Trails

Session 3:Cancer Immunology & Immunotherapy

Cancer immunology is a branch of immunology that studies interactions between the immune system and cancer cells (also called tumours or malignancies). It is a field of research that aims to discover cancer immunotherapies to treat and retard progression of the disease. The immune response, including the recognition of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

  • Host-Tumour Relation
  • Cancer Immunosurveillance and Immunoediting
  • Clinical Cancer immunology
  • Cancer Antigens & Vaccines
  • Cellular Immunotherapy
  • Antibody Therapy
  • Cytokine Therapy
  • Combination & Combinatorial Ablation and Immunotherapies

Session 4:Lifestyle and Nutrition for Cancer

Many factors influence the development of cancer. Over the last 25 years, science has shown that diet, physical activity, and body weight, especially being overweight or obese are major risk factors for developing certain types of cancer. Around a third of the most common cancers could be prevented through lifestyle changes. The body’s ability to resist cancer may be helped by following a healthy diet, staying physically active, and avoiding excess body fat. Cancer and cancer treatments can also affect your body's ability to tolerate certain foods and use nutrients.

  • Lifestyle Factors
  • Combined Impact
  • Population Attributable Risks
  • Investigation into Cancer and Nutrition (EPIC)

Session 5:Cancer screening

Unlike diagnostic efforts prompted by symptoms and medical signs, cancer screening involves efforts to detect cancer after it has formed, but before any noticeable symptoms appear. This may involve physical examination, blood or urine tests or medical imaging.

Cancer screening is not available for many types of cancers. Even when tests are available, they may not be recommended for everyone.Several factors are considered to determine whether the benefits of screening outweigh the risks and the costs of screening.

  • Screening mammography
  • Prostate Cancer Screening
  • Pancreatic Cancer Screening
  • Oral Cancer Screening
  • Lung Cancer Screening
  • Colorectal Cancer Screening
  • Cervical Cancer Screening
  • Breast Cancer Screening
  • Whole Body Imaging
  • Innovation in Genetic Testing

Session 6:Organ Specific Cancer

Malignant growth depends on the area of disease cells happen specifically organ. There are more than 200 different types of cancer diagnosed. Among them, Lung cancer, breast cancer is the most common cancer diagnosed in 2015. Apart from this prostate cancer, colon cancers, bladder cancer, breast cancer are the most common type cancer. The rare types of cancers are which affect the bone known as Bone Cancer. Depending upon the location of cancer the causes, symptoms, and method of treatments vary. Carcinoma, Sarcoma, leukaemia, lymphoma, and melanoma are the types of cancer found in different organs.

  •  Hemato-oncology
  •  Head & Neck Oncology
  •  Urological Oncology

 

Session 7:Cancer Genetics and Epigenetics

Risk expectation and prediction and Cancer prevention, growth counteractive action is also promising and encouraging areas of Epigenetics. A high adequacy of demethylating agents were accounted for essentially in haematological malignancies in view of new conventions with low dose and long exposure, and their utilization is presently being striven for strong tumours. During the cell’s transformation to Cancerous cell, Epigenetic modifications are also more important like genetic mutation. Their manipulation brings a great promising approach for inventing, detecting and treatment of cancer.

  • Diseases
  • Clinical Applications
  • Pharmacogenomics
  • Mutations
  • Germ Line Changes
  • Hereditary Cancer Syndrome

Session 8:Cancer Metastasis

Cancer that spread to a different part of the body from where it started is called metastasis. For example, a breast cancer that spread to the liver is referred to as metastatic breast cancer. The most common sites where cancer spreads are the bone, liver, and lung. The clinical manifestation of metastasis in a vital organ is the ultimate phase of cancer progression and the main offender of cancer-related mortality.

  • Pathophysiology
  • Organ-Specific Targets
  • Diagnosis & Management
  • Multimodal therapies

 Session 9:Pathology In Cancer

Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey. Diagnosis and staging are just the beginning of a cancer pathologist’s work. He or she also studies the tumour’s molecular structure to determine whether it is likely to be sensitive to certain chemotherapy drugs, hormone treatments or other cancer therapies.. Making good use of that expertise is not limited to determining a diagnosis or recommending treatment options.

  • Anatomical Pathology
  • Oncopathology
  • Molecular pathology of cancer
  • Pathology in cancer diagnostics
  • Cancer Cytopathology
  • Forensic Pathology
  • Pediatric pathology

Session 10:Cancer Bioinformatics & Biomarkers

Cancer Bioinformatics:

It is another integrated region including organic, measurable and computational sciences. Now a day’s bioinformatics modification is for the most part utilized for the special growth investigation. Ribosomal S6 protein kinase 4 (RSK4) is a fundamental novel tumour silencer that binds breast cancer cell development and commence senescence. Utilizing pair proclivity cleaning, we got protein buildings that correlate with RSK4 or RSK4m. Mass range examination was performed to differentiate the acquired protein edifices, and bioinformatics investigation was performed.

  • Cancer Bioinformatics
  • Translational Bioinformatics
  • Bioinformatics Gene
  • Bioinformatics Drug
  • Biology Bioinformatics

Cancer Biomarkers:

The Cancer Biomarkers are the substance that acts as an indicator of the cancer site in the body. Usually the biomarker is a computable indicator of biological state in the body; it is a molecule which is unleashed by the tumour or in response to the presence of tumour. The biomarkers are used for the assessment of risk for cancer patients.The cancer prognosis can also be determined by the biomarkers. In prognosis, the forcefulness of the recognized cancer and the response to the given treatment

  • Diagnosis and Risk assessment
  • Prognosis and Treatment
  • Biomarkers in cancer development research
  • Biomarkers in drug

Session 11:Radiation Therapy and its side effects

It is one of the cancer treatment techniques. In Radiation therapy by the usage of ionizing radiation the cancer cells will be damaged. In this process of radiation therapy some normal cells also effects. Mostly, normal cells can recover from these effects and work properly.  Meanwhile, in this process some surrounding healthy organs also effects. Radiation therapy does depend on various factors like type of cancer and sensitivity and some other. This radiation therapy can also be used as a part of adjuvant therapy.

  • Distinguish the radio sensitivity of a particular tumour
  • Damaging the DNA of cancerous cells
  • 3-dimensional confirmation radiation therapy
  • Radio surgery
  • Intensity-modulated radiation therapy

Session 12:Cancer Stem Cell Therapy

Cells which are present in tumour and have the capabilities of self-renewing and ability to give rise to many cells are known as cancer stem cells. Cancer stem cell model also known as hierarchical model process. Cellular therapies are a part of complimentary treatment regimens.

  • Stem cell mutation
  • Cancer stem cell and immunology model
  • Stochastic model

 

Market analysis

Cancer is the name given to a collection of related diseases. In all types of cancer, some of the body’s cells begin to divide without stopping and spread into surrounding tissues. Cancer can start almost anywhere in the human body, which is made up of trillions of cells. Normally, human cells grow and divide to form new cells as the body needs them. When cells grow old or become damaged, they die, and new cells take their place. When cancer develops, however, this orderly process breaks down. As cells become more and more abnormal, old or damaged cells survive when they should die, and new cells form when they are not needed. These extra cells can divide without stopping and may form growths called tumors.

 

Targeted Audience

  • Professors and Students from Academia in the study of Oncology and artificial intelligence field.
  • Artificial Intelligence Lab Directors/Associates
  • Artificial intelligence researchers and academicians
  • Academic analysts
  • Health care professionals
  • Research faculty
  • Artificial Oncologists
  • Industry authorities
  • Public prosperity aspects
  • Academic Professors
  • Pharmaceutical Companies and Markets
  • Students from Artificial Intelligence, Oncology , and Automation Engineering

 

Past conference reports

Cancer and Care 2020

Conference series LLC Ltd hosted the “International Conference on Cancer and Care” during December 07-08, 2020 in Paris, France  with the theme “Exploring Advancements in Cancer Care”. It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent  presence addressed the gathering. The adepts who promulgated the theme with their exquisite talks were:Stephanie Merck(USA)Ann Mitchell (USA), Eric Loftsgaarden(USA), JiYeong Seo(South Africa), Debra Parker (USA).Scientific sessions discussed during conference are about Cancer Prevention and Cure, Cancer Vaccines ,Cancer Immunology & Immunotherapy, Lifestyle and Nutrition for Cancer, Cancer screening.

Cancer  Pathology 2019

Conference series LLC Ltd hosted the “15th International Conference on Surgical Pathology and Cancer Diagnosis”during April 15-16th, 2019  in Golden Tulip Berlin Hotel Hamburg Landgrafenstraße, Berlin, Germany with the theme “The good physicians treat the disease; the great physicians treat the patient who has the disease”.It was a great success where eminent speakers from various reputed institutions and organizations with their resplendent  presence addressed the gathering.The adepts who promulgated the theme with their exquisite talk were: Dana Buchbut (USA) , Roberto N Miranda (USA), Dr Maria Teresa (Italy), John Zhong(USA),  Shahla Masood (USA).Scientific sessions discussed during conference are about Neuromuscular Pathology,  Ophthalmic Pathology, Dermatopathology, Hematopathology, Histological Pathology.

Cancer diagnostics Conference 2018

Conference series LLC Ltd hosted the “International Conference on Cancer Research and Diagnostics” during August 15-16, 2018 in  Singapore with the theme “Cancer survived is a life revived”.It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent  presence addressed the gathering. The adepts who promulgated the theme with their exquisite talk were Eisha Tahir (Pakistan) , Lingzhi WANG (Singapore), Dr Masakatsu Fukuda (Japan), Dr Kyoung Jin Kim (South Korea),  Auj-E Taqaddas (Canada).Scientific sessions discussed during conference are about  Nanotechnology in cancer, Recent diagnostic techniques , Cancer screening and prevention , Cancer immunotherapy and types , Cancer diagnostics market.

GI Cancer 2017

Conference series LLC Ltd hosted the “International Conference on Gastrointestinal Cancer and Therapeutics” during October 16-18, 2017 in Baltimore, USA  with the theme “Care about Gastrointestinal cancer for healthy lifestyle”. It was a great success, where eminent speakers from various reputed institutions and organizations with their resplendent  presence addressed the gathering.The adepts who promulgated the theme with their exquisite talk were ZhichenXiao (Australia) , Jerzy Leszek (Poland) , LindaLevineMadori(USA) , TohruHasegawa (USA) , Claude M Wischik (UK)Scientific sessions discussed during conference are about  Gall Bladder Cancer , Esophageal Cancer , Gastrointestinal Cancer: Causes , Gastrointestinal Cancer: Diagnosis , Stomach Cancer.

 

 

 

  •  

To Collaborate Scientific Professionals around the World

Conference Date April 18-19, 2022

For Sponsors & Exhibitors

[email protected]

Speaker Opportunity

Past Conference Report

Supported By

Oncology & Cancer Case Reports Journal of Cancer Science and Research Journal of Experimental & Clinical Cancer Research

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by